News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Yüksel Ürün: US FDA approves mirvetuximab soravtansine-gynx for FRα+ platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer
Mar 28, 2024, 03:11

Yüksel Ürün: US FDA approves mirvetuximab soravtansine-gynx for FRα+ platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer

Yüksel Ürün, Professor of Medical Oncology at Ankara University School of Medicine, shared a post on X:

“US FDA approves mirvetuximab soravtansine-gynx for FRα+ platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer!”

Yüksel Ürün: US FDA approves mirvetuximab soravtansine-gynx for FRα+ platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer

View additional information.

Source: Yüksel Ürün/X

Ankara University School of Medicine cancer fallopian tube cancer FDA approval Mirvetuximab Mirvetuximab Soravtansine OncoDaily Oncology Ovarian Cancer primary peritoneal cancer soravtansine-gynx US FDA Yüksel Ürün
Special Coverage
Insight
Jul 29, 2025, 15:41
Best Immunotherapy Highlights from ESMO TAT ASIA 2025 You Shouldn't Miss
Oncolibrary
Jul 29, 2025, 12:29
New Paper Alert: TUXEDO-3 Trial Demonstrates Clinical Activity of Patritumab Deruxtecan in Leptomeningeal Metastases from Solid Tumors
Insight
Jul 29, 2025, 11:49
Why Do Viruses Act So Differently? - Sbarro Health Research Organization
Insight
Jul 29, 2025, 11:22
Miguel Bronchud: Prostate Cancer Treatments Continue to Evolve
Blog
Jul 29, 2025, 11:19
Afreen Shariff: How Lack of Common Language Creates Confusion in Medicine
Blog
Jul 29, 2025, 11:18
How Immune Cells Could be Undermining the Cancer-fighting Ability of Engineered Cell Therapies - MSKCC
Blog
Jul 29, 2025, 11:05
Voice of the Families: Mahlet and Her Father - CANCaRe Africa
Insight
Jul 29, 2025, 10:43
Bar Levy: New ESGO-ESTRO-ESP Guidelines for Endometrial Cancer
Blog
Jul 29, 2025, 10:21
The CCI Europe Committee Met in Vienna for the Bi-annual Strategic Meeting
Insight
Jul 29, 2025, 10:05
Celebrating New FASCO Members
Blog
Jul 29, 2025, 10:02
The Best RTT Paper Award at ESTRO25
Blog
Jul 29, 2025, 09:52
Sachin H. Jain: Is Modulating Communication One of the Hardest and Most Underrated Leadership Skills?